ATE390142T1 - Synergistische zusammensetzung zur behandlung von diabetes mellitus - Google Patents
Synergistische zusammensetzung zur behandlung von diabetes mellitusInfo
- Publication number
- ATE390142T1 ATE390142T1 AT04732676T AT04732676T ATE390142T1 AT E390142 T1 ATE390142 T1 AT E390142T1 AT 04732676 T AT04732676 T AT 04732676T AT 04732676 T AT04732676 T AT 04732676T AT E390142 T1 ATE390142 T1 AT E390142T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- diabetes mellitus
- synergistic composition
- concentration ranging
- composition
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 3
- 230000002195 synergetic effect Effects 0.000 title 1
- WWNNZCOKKKDOPX-UHFFFAOYSA-N N-methylnicotinate Chemical compound C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000654 additive Substances 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000000835 fiber Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47074203P | 2003-05-14 | 2003-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE390142T1 true ATE390142T1 (de) | 2008-04-15 |
Family
ID=33452413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04732676T ATE390142T1 (de) | 2003-05-14 | 2004-05-13 | Synergistische zusammensetzung zur behandlung von diabetes mellitus |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US7141254B2 (de) |
| EP (1) | EP1638586B1 (de) |
| JP (1) | JP4353982B2 (de) |
| AT (1) | ATE390142T1 (de) |
| DE (1) | DE602004012745T2 (de) |
| DK (1) | DK1638586T3 (de) |
| WO (1) | WO2004100968A2 (de) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7815946B1 (en) * | 2001-04-05 | 2010-10-19 | Diakron Pharmaceuticals, Inc. | Anti-diabetic and cholesterol lowering preparation from fenugreek seeds |
| ATE390142T1 (de) * | 2003-05-14 | 2008-04-15 | Indus Biotech Pvt Ltd | Synergistische zusammensetzung zur behandlung von diabetes mellitus |
| WO2005049006A1 (ja) * | 2003-11-21 | 2005-06-02 | Ajinomoto Co., Inc. | 糖尿病治療剤 |
| BRPI0607156A2 (pt) * | 2005-02-18 | 2009-08-11 | Innodia Inc | composto, composição farmacêutica, uso do composto, kit farmacêutico, método para estimular a absorção de glicose por células de músculo e/ou célula de adipócito e método para estimular a secreção pancreática |
| BRPI0611550A2 (pt) * | 2005-03-22 | 2009-01-13 | Innodia Inc | uso de um composto selecionado do grupo que consiste em isâmeros de 4-hidràxi isoleucina, anÁlogos de 4-hidràxi isoleucina, e lactonas, sais, metabàlitos, solvatos e/ou prà-medicamentos farmaceuticamente aceitÁveis dos ditos isâmeros e anÁlogos, composto, kit farmacÊutico, composiÇço farmacÊutica, uso do composto e kit com composto |
| WO2007041643A1 (en) * | 2005-10-03 | 2007-04-12 | University Of Tennessee Research Foundation | Dietary calcium for reducing the production of reactive oxygen species |
| US20100048545A1 (en) * | 2006-03-22 | 2010-02-25 | Innodia Inc. | Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity |
| EP1859786A1 (de) * | 2006-05-16 | 2007-11-28 | Frutarom Netherlands B.V. | Methode zu vermindern die Symptome von Sodbrennen und Gastro-speiseröhren Rücklaufkrankheit durch spezifischen polysaccharides |
| WO2007138609A1 (en) * | 2006-06-01 | 2007-12-06 | Department Of Biotechnology | Method of preparing dialysed extract of fenugreek seeds |
| US20080075792A1 (en) * | 2006-09-21 | 2008-03-27 | Naturalendo Tech Co., Ltd. | Method for inhibiting the activity of DPP-IV and lowering blood glucose level |
| US20080199517A1 (en) * | 2007-02-19 | 2008-08-21 | Indus Biotech Private Ltd | Composition and a process thereof |
| CA2679206C (en) * | 2007-03-05 | 2015-02-24 | Indus Biotech Private Limited | Pharmaceutical compositions comprising trigonelline and 4-hydroxyisoleucine and a process thereof |
| US20080228056A1 (en) * | 2007-03-13 | 2008-09-18 | Michael Blomquist | Basal rate testing using frequent blood glucose input |
| US7751907B2 (en) | 2007-05-24 | 2010-07-06 | Smiths Medical Asd, Inc. | Expert system for insulin pump therapy |
| US8221345B2 (en) | 2007-05-30 | 2012-07-17 | Smiths Medical Asd, Inc. | Insulin pump based expert system |
| US20090177147A1 (en) | 2008-01-07 | 2009-07-09 | Michael Blomquist | Insulin pump with insulin therapy coaching |
| US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
| CA2723131C (en) * | 2008-05-08 | 2013-09-03 | Indus Biotech Private Limited | Compositions comprising galactomannan and a process thereof |
| US8288364B2 (en) * | 2008-05-09 | 2012-10-16 | Indus Biotech Private Limited | Botanically derived composition and a process thereof |
| IN2008DE01521A (de) * | 2008-06-25 | 2015-10-02 | Dept Of Biotechnolgoy | |
| MX373366B (es) | 2008-08-15 | 2025-03-05 | Ironwood Pharmaceuticals Inc | Formulaciones que contienen linaclotida para administracion oral. |
| US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
| EP2334234A4 (de) | 2008-09-19 | 2013-03-20 | Tandem Diabetes Care Inc | Vorrichtung zur messung der konzentration eines gelösten stoffs und entsprechende verfahren |
| JP2012508781A (ja) * | 2008-11-17 | 2012-04-12 | テヒニシェ ウニヴェルズィテート ミュンヘン | 糖尿病の治療又は予防に使用されるピリミジニウム誘導体 |
| AU2010278894B2 (en) | 2009-07-30 | 2014-01-30 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
| JP2013501071A (ja) * | 2009-08-06 | 2013-01-10 | アイロンウッド ファーマシューティカルズ， インコーポレイテッド | リナクロチドを含む処方物 |
| US8882701B2 (en) | 2009-12-04 | 2014-11-11 | Smiths Medical Asd, Inc. | Advanced step therapy delivery for an ambulatory infusion pump and system |
| AU2011218009B2 (en) | 2010-02-17 | 2016-11-03 | Ironwood Pharmaceuticals, Inc | Treatments for gastrointestinal disorders |
| SG184451A1 (en) | 2010-04-07 | 2012-11-29 | Otsuka Pharma Co Ltd | Composition for amelioration of hypoalbuminemia |
| SI2603232T1 (sl) | 2010-08-11 | 2020-03-31 | Ironwood Pharmaceuticals, Inc. | Stabilne formulacije linaklotida |
| CN102697781B (zh) * | 2011-06-21 | 2013-12-04 | 中国人民解放军第三军医大学第二附属医院 | 胡芦巴碱作为制备防治糖尿病及其并发症药物的应用 |
| CN102225082B (zh) * | 2011-06-22 | 2017-05-24 | 中国人民解放军第三军医大学第二附属医院 | 一种防治糖尿病及其并发症的药物和其制备方法 |
| RU2631597C2 (ru) | 2011-07-15 | 2017-09-25 | Нусерт Сайенсиз, Инк. | Композиции и способы модулирования метаболических путей |
| US9708371B2 (en) | 2011-08-17 | 2017-07-18 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
| US9198454B2 (en) | 2012-03-08 | 2015-12-01 | Nusirt Sciences, Inc. | Compositions, methods, and kits for regulating energy metabolism |
| US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
| US9555186B2 (en) | 2012-06-05 | 2017-01-31 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
| US9238100B2 (en) | 2012-06-07 | 2016-01-19 | Tandem Diabetes Care, Inc. | Device and method for training users of ambulatory medical devices |
| CN108295058A (zh) | 2012-11-13 | 2018-07-20 | 纽斯尔特科学公司 | 用于增强能量代谢的组合物和方法 |
| US10201656B2 (en) | 2013-03-13 | 2019-02-12 | Tandem Diabetes Care, Inc. | Simplified insulin pump for type II diabetics |
| US10357606B2 (en) | 2013-03-13 | 2019-07-23 | Tandem Diabetes Care, Inc. | System and method for integration of insulin pumps and continuous glucose monitoring |
| US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
| US10016561B2 (en) | 2013-03-15 | 2018-07-10 | Tandem Diabetes Care, Inc. | Clinical variable determination |
| KR20150130455A (ko) | 2013-03-15 | 2015-11-23 | 뉴서트 사이언시스, 인크. | 지질 수준을 감소시키는 류신 및 니코틴산 |
| US9492608B2 (en) | 2013-03-15 | 2016-11-15 | Tandem Diabetes Care, Inc. | Method and device utilizing insulin delivery protocols |
| EP2981259B1 (de) * | 2013-04-02 | 2021-06-09 | Indus Biotech Private Limited | Zusammensetzung zur behandlung von neuropathie sowie prozess und verfahren zur behandlung davon |
| MX2016011063A (es) | 2014-02-27 | 2016-11-30 | Nusirt Sciences Inc | Composiciones y metodos para la reduccion o prevencion de esteatosis hepatica. |
| EP3174577A4 (de) | 2014-07-30 | 2018-04-18 | Tandem Diabetes Care, Inc. | Temporäre suspendierung für arzneimitteltherapie mit geschlossenem regelkreis |
| WO2017021983A1 (en) * | 2015-08-06 | 2017-02-09 | Rubicon Research Private Limited | Particulate delivery systems |
| US10569016B2 (en) | 2015-12-29 | 2020-02-25 | Tandem Diabetes Care, Inc. | System and method for switching between closed loop and open loop control of an ambulatory infusion pump |
| JP7072357B2 (ja) * | 2016-08-24 | 2022-05-20 | 公益財団法人東洋食品研究所 | 糖取り込み組成物 |
| EP3479845A1 (de) * | 2017-11-06 | 2019-05-08 | Stalicla S.A. | Belastungsprobe zur diagnose des subtyps von erkrankungen im autismusbereich |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2695317B1 (fr) * | 1992-09-07 | 1995-03-10 | Monal Lab | Composition apte à stimuler la sécrétion d'insuline destinée au traitement du diabète non insulino-dépendant. |
| IL108583A (en) * | 1994-02-07 | 1997-06-10 | Yissum Res Dev Co | Galactomannan emulsions and comestible products containing the same |
| CA2206157C (en) * | 1997-05-26 | 2000-06-13 | Cheng, Peter | Method of extraction of commercially valuable fractions of fenugreek |
| IN192689B (de) * | 2000-02-14 | 2004-05-15 | Rao Gariimella Bhaskar Dr | |
| JP3947012B2 (ja) * | 2001-01-22 | 2007-07-18 | リー，スン−ヨン | 糖尿病治療用組成物 |
| ATE390142T1 (de) * | 2003-05-14 | 2008-04-15 | Indus Biotech Pvt Ltd | Synergistische zusammensetzung zur behandlung von diabetes mellitus |
-
2004
- 2004-05-13 AT AT04732676T patent/ATE390142T1/de not_active IP Right Cessation
- 2004-05-13 WO PCT/IB2004/001550 patent/WO2004100968A2/en active IP Right Grant
- 2004-05-13 JP JP2006530649A patent/JP4353982B2/ja not_active Expired - Lifetime
- 2004-05-13 DK DK04732676T patent/DK1638586T3/da active
- 2004-05-13 EP EP04732676A patent/EP1638586B1/de not_active Expired - Lifetime
- 2004-05-13 DE DE602004012745T patent/DE602004012745T2/de not_active Expired - Lifetime
- 2004-05-14 US US10/846,299 patent/US7141254B2/en not_active Expired - Lifetime
-
2006
- 2006-02-15 US US11/355,868 patent/US7674485B2/en active Active
- 2006-02-15 US US11/356,274 patent/US7641925B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004100968A2 (en) | 2004-11-25 |
| JP4353982B2 (ja) | 2009-10-28 |
| US7641925B2 (en) | 2010-01-05 |
| EP1638586B1 (de) | 2008-03-26 |
| US7141254B2 (en) | 2006-11-28 |
| JP2006528235A (ja) | 2006-12-14 |
| US20050008716A1 (en) | 2005-01-13 |
| US7674485B2 (en) | 2010-03-09 |
| US20060134242A1 (en) | 2006-06-22 |
| DK1638586T3 (da) | 2008-06-23 |
| DE602004012745T2 (de) | 2009-04-09 |
| US20060153937A1 (en) | 2006-07-13 |
| EP1638586A2 (de) | 2006-03-29 |
| WO2004100968A3 (en) | 2005-01-20 |
| DE602004012745D1 (de) | 2008-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE390142T1 (de) | Synergistische zusammensetzung zur behandlung von diabetes mellitus | |
| CY1123084T1 (el) | Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι | |
| ATE320803T1 (de) | Verfahren zur behandlung von alzheimerschen krankheit | |
| UY27438A1 (es) | Composición farmaceútica que comprende un conjugado oligómero-farmaco insulina, método para tratar deficiencia de insulina en un sujeto, método para proveer una composición farmacéutica. | |
| ATE556711T1 (de) | Verfahren zur verbesserung der hautqualität | |
| EA200501592A1 (ru) | Способы и композиции для введения агонистов trpv1 | |
| EP1505990A4 (de) | Verfahren zur behandlung von hepatitis | |
| DE60115433D1 (de) | Verfahren zur behandlung von chronischen geschwüren | |
| ATE453402T1 (de) | Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis | |
| DE69829202D1 (de) | Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen | |
| ATE201598T1 (de) | Verwendung von moxonidin zur behandlung neuropathischer schmerzen | |
| ATE281841T1 (de) | Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen | |
| DE69818809D1 (de) | Verfahren zur behandlung von narbengewebe | |
| ATE291425T1 (de) | R-eliprodil zur behandlung von glaucoma | |
| DE69734349D1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
| DE60236299D1 (de) | Valeriana officinalis extrakt zur behandlung von schlafapnoe oder hypopnoe | |
| SE0301947D0 (sv) | New method and uses | |
| DE60313344D1 (de) | Verwendung von 4-pyridylmethyl-phthalazin-derivaten zur herstellung eines medikaments zur behandlung von myelodysplastischen syndromen | |
| DE60134656D1 (de) | Hilfsmittel und methoden zur transdermalen applikation von felodipin | |
| DE602004021395D1 (de) | Verfahren zur behandlung von hepatozellulärem karzinom | |
| ATE439136T1 (de) | Verfahren zur behandlung von halitose | |
| UA6151U (en) | Method for treating experimental burns | |
| YU93502A (sh) | Žučne kiseline i njihovi derivati kao poboljšivači dejstva hipoklikemika | |
| RU2004123072A (ru) | Способ лечения больных остеоартрозом |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |